Sun Li-Qiang, Takaki Katherine, Chen Jie, Bertenshaw Stephen, Iben Lawrence, Mahle Cathy D, Ryan Elaine, Wu Dedong, Gao Qi, Xu Cen
Bristol-Myers Squibb Pharmaceutical Research Institute, 5 Research Parkway, Wallingford, CT 06492, USA.
Bioorg Med Chem Lett. 2005 Mar 1;15(5):1345-9. doi: 10.1016/j.bmcl.2005.01.015.
(R)-2-(4-Phenylbutyl)dihydrobenzofuran derivatives (e.g., 3 and 4) were synthesized as novel melatoninergic ligands with significantly lower vasoconstrictive activity in vitro in the rat tail artery. Binding affinity assays were performed on cloned human MT1 and MT2 receptors stably expressed in NIH3T3 cells.